Appraisal of Non-Cardiovascular Safety for Sodium-Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials

• Main Authors: Fang-Hong Shi (Author), Hao Li (Author), Long Shen (Author), Zhen Zhang (Author), Yi-Hong Jiang (Author), Yao-Min Hu (Author), Xiao-Yan Liu (Author), Zhi-Chun Gu (Author), Jing Ma (Author), Hou-Wen Lin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Whereas the cardiovascular safety of sodium-glucose co-transporter 2 (SGLT2) inhibitors has been well reported, there is limited data from controlled clinical trials regarding the non-cardiovascular safety. This was the focus of our study.Methods and Findings: We systematically searched...